Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire

The same is true in the more neglected scenario of paediatric nutrition, where low muscle mass is emerging as an important problem with little past or ongoing research to inform clinical practice. 13,14 This lack of targeted nutrient recommendations may also impact the optimal use of nutrition strategies within multimodal interventions, which are recognised as ideal for multifactorial conditions. 1 Figure. Articles also explored the associations of protein intake, 46,47 iron deficiency, 37,42 micronutrients, 35 calorie restriction, 43 nitrate dietary intake, 36 retrospective evaluation of early dietary supplementation, 44 and overall dietary intake and patterns 34 with several clinical outcomes and/or biomarkers of sarcopenia or cachexia. Two studies evaluated the perceptions of oncology patients regarding disease‐related nutritional issues and barriers to effective nutritional interventions. 45,48 One narrative review discussed potential nutrition interventions to augment muscle mass. 6 Call for papers Acknowledging the role of nutrition to counter cachexia, sarcopenia, and other muscle loss diseases, and the small number of publications in the topic, JSCM is launching a call for papers on the role of nutrition in preventing and treating cachexia, sarcopenia, or other muscle loss diseases.